Press "Enter" to skip to content

Pharma Reviews

Explained: What Covaxin’s 81% interim vaccine efficacy means?

Bharat Biotech on Wednesday announced its Covid-19 vaccine candidate BBV152 Covaxin demonstrated 81% interim vaccine efficacy in its Phase 3 clinical trial. Original source:

Improper Use of Thermal Imaging Devices: FDA Safety Communication

The FDA is alerting consumers, health care providers and users that improper use of thermal imaging devices may provide inaccurate temperature readings. Original source:

Analyst-Pharma ERP

Analyst-Pharma ERP Job Description Skill required: Pharma ERP – SDTM (Study Data Tabulation Model) Mapping Designation: Management Level… to l Job Description Skill required: Pharma…

Bharat Biotech says Covid-19 vaccine shows 81% interim efficacy

The trials involved 25,800 participants and was conducted in partnership with the Indian government’s medical research body. Original source: